Tocqueville Asset Management’s MacroGenics MGNX Stock Holding History

Tocqueville Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100,000	Closed	-$1.85M	–	815
2017 Q3	$1.85M	Buy	100,000 +25,000	+33%	+$433K	0.02%	462
2017 Q2	$1.31M	Hold	75,000	–	–	0.02%	471
2017 Q1	$1.4M	Buy	+75,000	New	+$1.45M	0.02%	452
2016 Q4	–	Sell	-17,000	Closed	-$508K	–	833
2016 Q3	$508K	Hold	17,000	–	–	0.01%	628
2016 Q2	$459K	Hold	17,000	–	–	0.01%	651
2016 Q1	$319K	Hold	17,000	–	–	﹤0.01%	715
2015 Q4	$526K	Buy	17,000 +4,000	+31%	+$122K	0.01%	653
2015 Q3	$278K	Hold	13,000	–	–	﹤0.01%	824
2015 Q2	$494K	Buy	+13,000	New	+$427K	0.01%	721

Other funds holding MGNX

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tocqueville Asset Management's MGNX Position: Q4 2017 in Review

Tocqueville Asset Management sold out of MacroGenics (MGNX) in Q4 2017, closing a stake of 100,000 shares — an estimated $1.85M sold.

Tocqueville Asset Management first reported a position in MGNX in Q2 2015 and held it in 9 quarters. The position peaked at $1.85M in Q3 2017. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

Tocqueville Asset Management reported no remaining MacroGenics position as of Q4 2017 after selling out during the quarter.
Tocqueville Asset Management sold 100,000 MacroGenics shares in Q4 2017, an estimated $1.85M.
Tocqueville Asset Management first reported a position in MacroGenics in Q2 2015 and held it in 9 quarters.
Tocqueville Asset Management's MacroGenics position peaked at $1.85M in Q3 2017.
119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Tocqueville Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.